文献速递神经肿瘤

蛋白激酶CK2对胶质母细胞瘤脑肿瘤起始细胞的功能至关重要

Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells.
PubMed 文献 · J Neurooncol · 2017-02-08

研究探讨蛋白激酶CK2在胶质母细胞瘤脑肿瘤起始细胞(BTIC)中的作用。发现CD133+ BTIC中CK2α表达高于CD133-细胞;CX-4945抑制CK2可降低Sox2和Nestin表达、减少CD133+ BTIC频率及神经球形成,并降低部分异种移植系的EGFR水平;CX-4945与吉非替尼联合可最佳抑制细胞活力。作者认为CK2是胶质母细胞瘤有前景的靶点。

要点

  • CD133+ BTIC中CK2α表达较CD133-细胞增高
  • CX-4945抑制CK2可降低Sox2和Nestin表达并减少CD133+ BTIC频率
  • CX-4945或siRNA敲低CK2催化亚基可减少不同分子亚型GBM异种移植系的神经球形成

核心结论

  • 由于CK2整合于多个对BTIC生存重要的信号通路,CK2是胶质母细胞瘤中有前景的靶点。

研究设计与样本

  • 研究在胶质母细胞瘤异种移植系中检查CK2信号对脑肿瘤起始细胞功能的作用,使用CX-4945及siRNA敲低CK2催化亚基,并以体外有限稀释法评估神经球形成。

主要发现

  • 在同一GBM异种移植系内,CD133+ BTIC中CK2α表达较CD133-细胞增高。
  • CX-4945处理导致维持干细胞重要的转录因子Sox2和Nestin表达降低。
  • 抑制CK2在7天内减少CD133+ BTIC频率,提示CK2在BTIC持续存在和生存中起作用。
  • 用CX-4945抑制CK2激酶活性或siRNA敲低CK2催化亚基,减少不同分子亚型GBM异种移植系的神经球形成。
  • 抑制CK2导致部分异种移植系EGFR水平降低,CX-4945与吉非替尼分别抑制CK2和EGFR的联合处理对细胞活力提供最佳抑制。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Protein kinase CK2 is a ubiquitously expressed serine/threonine kinase composed of two catalytic subunits (α) and/or (α') and two regulatory (β) subunits. The expression and kinase activity of CK2 is elevated in many different cancers, including glioblastoma (GBM). Brain tumor initiating cells (BTICs) are a subset of cells that are highly tumorigenic and promote the resistance of GBM to current therapies. We previously reported that CK2 activity promotes prosurvival signaling in GBM. In this study, the role of CK2 signaling in BTIC function was examined. We found that expression of CK2α was increased in CD133+ BTICs compared to CD133- cells within the same GBM xenolines. Treatment with CX-4945, an ATP-competitive inhibitor of CK2, led to reduced expression of Sox2 and Nestin, transcription factors important for the maintenance of stem cells. Similarly, inhibition of CK2 also reduced the frequency of CD133+ BTICs over the course of 7 days, indicating a role for CK2 in BTIC persistence and survival. Importantly, using an in vitro limiting dilution assay, we found that inhibition of CK2 kinase activity with CX-4945 or siRNA knockdown of the CK2 catalytic subunits reduced neurosphere formation in GBM xenolines of different molecular subtypes. Lastly, we found that inhibition of CK2 led to decreased EGFR levels in some xenolines, and combination treatment with CX-4945 and Gefitinib to inhibit CK2 and EGFR, respectively, provided optimal inhibition of viability of cells. Therefore, due to the integration of CK2 in multiple signaling pathways important for BTIC survival, CK2 is a promising target in GBM.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Rowse AL, Gibson SA, Meares GP, et al. Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells. J Neurooncol. 2017. PMID: 28181105. doi:10.1007/s11060-017-2378-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。